Watanabe Todd
SEC CIK 1801061 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ARQT | Arcutis Biotherapeutics, Inc. | See Remarks, Dir | 717.2K | $30.6K | $8.42M | 73 | 2021-07-06 | 2026-08-03 |
Most active insiders at ARQT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Watanabe Todd | See Remarks, Dir | — | $5.32M |
| 2 | Welgus Howard G. | Dir | — | $2.43M |
| 3 | Matsuda Masaru | See Remarks | — | $2.21M |
| 4 | Burnett Patrick | See Remarks | — | $2.02M |
| 5 | Leonard Keith R | Dir | — | $997.1K |
| 6 | Curran Terrie | Dir | — | $984.0K |
| 7 | Edwards Larry Todd | See Remarks | — | $968.4K |
| 8 | Krishnamohan Neha | Dir | — | $939.5K |
| 9 | LIN SUE-JEAN | Dir | — | $898.5K |
| 10 | Gilbert Halley E | Dir | — | $455.5K |
Transactions 73
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-05 21:42 | 2026-08-03 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd | See Remarks, Dir | S - Sale | $26.12 | -4,375 | 717.2K | -0.6% | -$114.3K |
| T | 2026-05-06 18:06 | 2026-05-04 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd | See Remarks, Dir | S - Sale | $23.61 | -3,172 | 720.8K | -0.4% | -$74.9K |
| D | 2026-03-03 | 2026-02-27 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd | See Remarks, Dir | A - Grant | $0.00 | +102.0K | 823.3K | +14% | $0 |
| DM | 2026-03-03 | 2026-03-02 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd | See Remarks, Dir | S - Sale | $25.18 | -37.3K | 787.0K | -5% | -$940.5K |
| 2026-02-04 | 2026-02-02 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd | See Remarks, Dir | S - Sale | $25.50 | -19.8K | 721.3K | -3% | -$505.7K | |
| M | 2025-11-24 | 2025-11-21+ | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd | See Remarks, Dir | S - Sale | $30.35 | -50.0K | 793.8K | -6% | -$1.52M |
| M | 2025-11-05 | 2025-11-03 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd | See Remarks, Dir | S - Sale | $24.71 | -11.5K | 794.9K | -1% | -$285.4K |
| 2025-10-30 | 2025-10-28 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd | See Remarks, Dir | S - Sale | $25.03 | -40.0K | 806.4K | -5% | -$1.00M | |
| M | 2025-10-03 | 2025-10-01+ | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd | See Remarks, Dir | S - Sale | $19.66 | -45.0K | 867.2K | -5% | -$884.7K |
| M | 2025-09-10 | 2025-09-08+ | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd | See Remarks, Dir | S - Sale | $17.54 | -10.1K | 891.9K | -1% | -$177.7K |
| 2025-08-05 | 2025-08-04 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd | See Remarks, Dir | S - Sale | $14.33 | -11.5K | 901.6K | -1% | -$165.5K | |
| MI | 2025-06-12 | 2025-06-10 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks, Dir | G - Gift | $0.00 | +1,994 | 25.4K | +9% | $0 |
| M | 2025-06-12 | 2025-06-10 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks, Dir | G - Gift | $0.00 | -1,994 | 913.1K | -0.2% | $0 |
| 2025-05-05 | 2025-05-02 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks, Dir | S - Sale | $15.19 | -11.4K | 913.8K | -1% | -$173.9K | |
| M | 2025-03-26 | 2025-03-24+ | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks, Dir | S - Sale | $17.54 | -3,671 | 927.4K | -0.4% | -$64.4K |
| 2025-03-20 | 2025-03-17 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks, Dir | S - Sale | $17.61 | -1,200 | 928.9K | -0.1% | -$21.1K | |
| DM | 2025-03-04 | 2025-03-03+ | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks, Dir | S - Sale | $13.07 | -25.0K | 934.2K | -3% | -$327.0K |
| D | 2025-03-04 | 2025-02-28 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks, Dir | A - Grant | $0.00 | +151.0K | 955.1K | +19% | $0 |
| 2025-02-04 | 2025-02-03 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks, Dir | S - Sale | $12.70 | -19.3K | 804.1K | -2% | -$245.1K | |
| 2024-12-23 | 2024-12-20 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks, Dir | S - Sale | $15.17 | -15.0K | 823.4K | -2% | -$227.6K | |
| M | 2024-12-03 | 2024-05-31+ | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks, Dir | P - Purchase | $3.52 | +6,038 | 838.4K | +0.7% | +$21.3K |
| 2024-11-05 | 2024-11-04 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks, Dir | S - Sale | $8.68 | -13.9K | 832.4K | -2% | -$120.4K | |
| 2024-08-05 | 2024-08-02 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks, Dir | S - Sale | $9.02 | -14.5K | 846.3K | -2% | -$130.7K | |
| 2024-05-03 | 2024-05-02 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks, Dir | S - Sale | $8.74 | -13.8K | 860.8K | -2% | -$120.5K | |
| 2024-03-06 | 2024-03-04 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks, Dir | S - Sale | $11.12 | -14.9K | 874.5K | -2% | -$165.7K | |
| 2024-03-01 | 2024-02-28 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks, Dir | S - Sale | $10.60 | -2,465 | 889.4K | -0.3% | -$26.1K | |
| DM | 2024-02-15 | 2024-02-13 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks, Dir | A - Grant | — | +264.9K | 648.7K | +69% | — |
| D | 2024-01-17 | 2024-01-12 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks, Dir | A - Grant | $0.00 | +125.0K | 627.0K | +25% | $0 |
| M | 2023-12-22 | 2023-12-20 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks, Dir | G - Gift | $0.00 | -13.1K | 502.0K | -3% | $0 |
| MI | 2023-12-22 | 2023-12-20 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks, Dir | G - Gift | $0.00 | +13.1K | 24.4K | +116% | $0 |
| D | 2023-12-01 | 2023-12-01 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks, Dir | M - OptEx | $1.68 | +59.5K | 513.7K | +13% | +$100.0K |
| D | 2023-12-01 | 2023-05-31 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks, Dir | P - Purchase | $6.38 | +1,463 | 515.1K | +0.3% | +$9,334 |
| DA | 2023-03-31 | 2023-03-02 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks, Dir | A - Grant | $0.00 | +87.5K | 456.6K | +24% | $0 |
| 2023-03-08 | 2023-03-06 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks, Dir | S - Sale | $15.26 | -2,435 | 366.7K | -0.7% | -$37.2K | |
| M | 2023-03-02 | 2023-02-28+ | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks, Dir | S - Sale | $15.93 | -7,815 | 369.1K | -2% | -$124.5K |
| M | 2023-02-15 | 2023-02-13+ | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks, Dir | S - Sale | $17.01 | -1,000 | 377.0K | -0.3% | -$17.0K |
| M | 2023-02-03 | 2023-02-01 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks, Dir | S - Sale | $17.00 | -1,000 | 377.9K | -0.3% | -$17.0K |
| 2022-12-09 | 2022-12-07 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks, Dir | S - Sale | $17.06 | -1,000 | 378.9K | -0.3% | -$17.1K | |
| 2022-11-09 | 2022-11-07 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks, Dir | S - Sale | $18.00 | -1,000 | 379.9K | -0.3% | -$18.0K | |
| 2022-10-11 | 2022-10-07 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | S - Sale | $19.51 | -1,000 | 380.9K | -0.3% | -$19.5K | |
| 2022-09-09 | 2022-06-23 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | G - Gift | $0.00 | -269.0K | 382.9K | -41% | $0 | |
| 2022-09-09 | 2022-09-07 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | S - Sale | $21.51 | -1,000 | 381.9K | -0.3% | -$21.5K | |
| D | 2022-08-09 | 2022-08-05 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | M - OptEx | $1.68 | +2,500 | 654.4K | +0.4% | +$4,200 |
| D | 2022-08-09 | 2022-08-05 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | S - Sale+OE | $24.74 | -2,500 | 651.9K | -0.4% | -$61.8K |
| DM | 2022-07-12 | 2022-07-08 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | S - Sale+OE | $25.36 | -13.5K | 651.9K | -2% | -$342.4K |
| D | 2022-07-12 | 2022-07-08 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | M - OptEx | $1.68 | +7,087 | 659.0K | +1% | +$11.9K |
| 2022-07-07 | 2022-07-06 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | S - Sale | $22.07 | -1,000 | 658.3K | -0.2% | -$22.1K | |
| 2022-06-06 | 2022-06-06 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | S - Sale | $21.06 | -1,000 | 659.3K | -0.2% | -$21.1K | |
| 2022-05-05 | 2022-05-05 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | S - Sale | $21.76 | -1,000 | 658.7K | -0.2% | -$21.8K | |
| 2022-04-05 | 2022-04-05 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | S - Sale | $21.43 | -1,000 | 659.7K | -0.2% | -$21.4K | |
| 2022-03-11 | 2022-03-09 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | S - Sale | $17.00 | -300 | 660.7K | -0.0% | -$5,100 | |
| D | 2022-03-07 | 2022-03-07 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | M - OptEx | $1.68 | +700 | 661.7K | +0.1% | +$1,176 |
| DM | 2022-03-07 | 2022-03-04+ | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | S - Sale+OE | $16.90 | -3,259 | 661.0K | -0.5% | -$55.1K |
| D | 2022-03-07 | 2022-03-03 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | A - Grant | $0.00 | +70.9K | 663.5K | +12% | $0 |
| 2022-03-03 | 2022-03-01 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | S - Sale | $17.75 | -2,153 | 592.6K | -0.4% | -$38.2K | |
| D | 2022-02-11 | 2022-02-09 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | S - Sale+OE | $17.00 | -1,000 | 594.8K | -0.2% | -$17.0K |
| D | 2022-02-11 | 2022-02-09 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | M - OptEx | $1.68 | +1,000 | 595.8K | +0.2% | +$1,680 |
| DM | 2022-01-07 | 2022-01-05 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | S - Sale+OE | $21.59 | -1,000 | 594.8K | -0.2% | -$21.6K |
| D | 2022-01-07 | 2022-01-05 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | M - OptEx | $1.68 | +1,000 | 595.8K | +0.2% | +$1,680 |
| D | 2021-12-10 | 2021-12-08 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | M - OptEx | $1.68 | +1,000 | 595.8K | +0.2% | +$1,680 |
| D | 2021-12-10 | 2021-12-08 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | S - Sale+OE | $17.00 | -1,000 | 594.8K | -0.2% | -$17.0K |
| D | 2021-11-09 | 2021-11-05 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | M - OptEx | $1.68 | +1,000 | 595.8K | +0.2% | +$1,680 |
| D | 2021-11-09 | 2021-11-05 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | S - Sale+OE | $21.50 | -1,000 | 594.8K | -0.2% | -$21.5K |
| D | 2021-10-07 | 2021-10-05 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | S - Sale+OE | $24.92 | -2,500 | 594.8K | -0.4% | -$62.3K |
| D | 2021-10-07 | 2021-10-05 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | M - OptEx | $1.68 | +2,500 | 597.3K | +0.4% | +$4,200 |
| D | 2021-10-05 | 2021-10-01 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | S - Sale+OE | $25.01 | -1,500 | 594.8K | -0.3% | -$37.5K |
| D | 2021-10-05 | 2021-10-01 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | M - OptEx | $1.68 | +1,500 | 596.3K | +0.3% | +$2,520 |
| D | 2021-09-09 | 2021-09-07 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | S - Sale+OE | $21.14 | -1,000 | 594.8K | -0.2% | -$21.1K |
| D | 2021-09-09 | 2021-09-07 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | M - OptEx | $1.68 | +1,000 | 595.8K | +0.2% | +$1,680 |
| D | 2021-08-09 | 2021-08-05 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | M - OptEx | $1.68 | +1,000 | 595.8K | +0.2% | +$1,680 |
| D | 2021-08-09 | 2021-08-05 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | S - Sale+OE | $20.81 | -1,000 | 594.8K | -0.2% | -$20.8K |
| D | 2021-07-08 | 2021-07-06 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | S - Sale+OE | $26.58 | -1,750 | 594.8K | -0.3% | -$46.5K |
| D | 2021-07-08 | 2021-07-06 | ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | Pres, CEO, Dir | M - OptEx | $1.68 | +1,750 | 596.5K | +0.3% | +$2,940 |
Purchase Sale Sale after option exercise All abbreviations